Direct Application of Selective Laser Trabeculoplasty in Open Angle Glaucoma

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

August 31, 2019

Study Completion Date

November 30, 2019

Conditions
Glaucoma
Interventions
DEVICE

Direct Selective Trabeculoplasty device

Patients will be treated with a Direct Selective Trabeculoplasty (DLTP) laser. Placement of the spots is on the sclera around the limbus.

Trial Locations (1)

52621

The Sam Rothberg Glaucoma Center Goldschleger Eye Institute Sheba meical Center, Ramat Gan

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Horizon 2020 - European Commission

OTHER

lead

BelkinVision

INDUSTRY

NCT01383525 - Direct Application of Selective Laser Trabeculoplasty in Open Angle Glaucoma | Biotech Hunter | Biotech Hunter